As needed inhaled corticosteroids (ICS) plus long-acting beta-2 agonist (LABA) combination in children with mild asthma
Phase 3
Recruiting
- Conditions
- Health Condition 1: J453- Mild persistent asthma
- Registration Number
- CTRI/2023/08/057051
- Lead Sponsor
- Rashmi Ranjan Das
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Mild asthma or requiring Step 2 asthma treatment as per GINA 2023 guideline
Exclusion Criteria
1) History of hospitalization for =24 hrs for asthma in past 12 months
2) History of life threatening asthma requiring intensive care unit (ICU) admission
3) Use of ICS or LABA or Montelukast or sustained release Theophylline in past 6 months
4) History of known hypersensitivity or contraindication to any above drugs used
5) Behavioral or neuropsychiatry disorder
6) Use of systemic steroids in last 6 weeks
7) Unwilling to change the current asthma treatment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method